UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                       Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934



       Date of Report (date of earliest event reported): October 21, 2003


                           Commission File No. 0-11178
                                               -------


                           UTAH MEDICAL PRODUCTS, INC.
                           ---------------------------
             (Exact name of Registrant as specified in its charter)


                      UTAH                                87-0342734
         -------------------------------             ------------------
         (State or other jurisdiction of              (I.R.S. Employer
         incorporation or organization)              Identification No.)


                               7043 South 300 West
                               Midvale, Utah 84047
                              ---------------------
                     Address of principal executive offices


Registrant's telephone number:              (801) 566-1200
                                            --------------







--------------------------------------------------------------------------------

             ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION

--------------------------------------------------------------------------------



Attached hereto as Exhibit 99.1 and incorporated by reference herein is
financial information for Utah Medical Products, Inc. for the quarter ended
September 30, 2003 and forward- looking statements relating to the fourth
quarter of 2003 and beyond as presented in a press release dated October 21,
2003. The information in this report shall be deemed incorporated by reference
into any registration statement hertofore or hereafter filed under the
Securities Act of 1933, as amended, except to the extent that such information
is superseded by information as of a subsequent date that is included in or
incorporated by reference into such registration statement. The information in
this report shall not be treated as filed for purposes of the Securities
Exchange Act of 1934, as amended.


--------------------------------------------------------------------------------

                                   SIGNATURES

--------------------------------------------------------------------------------



     Pursuant to the requirements of the Securities Exchanges Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                     UTAH MEDICAL PRODUCTS, INC.
                                     ---------------------------
                                     REGISTRANT



Date:         10/21/03               By:  /s/ Kevin L. Cornwell
      ------------------------          ----------------------------
                                        Kevin L. Cornwell
                                        CEO


--------------------------------------------------------------------------------

                                  EXHIBIT INDEX

Index
Number         Description
------         -----------

99.1           Financial information for Utah Medical Products, Inc. for the
               quarter ended September 30, 2003 and forward-looking statements
               relating to the fourth quarter of 2003 and beyond as presented in
               a press release dated October 21, 2003.